Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_003560.4(PLA2G6):c.1942G>A(p.Gly648Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
PLA2G6 (HGNC:9039): (phospholipase A2 group VI) The protein encoded by this gene is an A2 phospholipase, a class of enzyme that catalyzes the release of fatty acids from phospholipids. The encoded protein may play a role in phospholipid remodelling, arachidonic acid release, leukotriene and prostaglandin synthesis, fas-mediated apoptosis, and transmembrane ion flux in glucose-stimulated B-cells. Several transcript variants encoding multiple isoforms have been described, but the full-length nature of only three of them have been determined to date. [provided by RefSeq, Dec 2010]
PLA2G6 Gene-Disease associations (from GenCC):
neurodegeneration with brain iron accumulation 2A
Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
neurodegeneration with brain iron accumulation 2B
Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
PLA2G6-associated neurodegeneration
Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
autosomal recessive Parkinson disease 14
Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
Our verdict: Pathogenic. The variant received 14 ACMG points.
PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_003560.4
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 22-38115619-C-T is Pathogenic according to our data. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-38115619-C-T is described in CliVar as Likely_pathogenic. Clinvar id is 242578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; In silico analysis, which includes splice predictors and evolutionary conservation, suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge -